In 2021, three full professors, 1 TT associate professor, 2 TT assistant professors, 4 professors by special appointment, 2 postdocs, 2 data managers, 10 lecturers, 5 support staff and 20 PhDs are affiliated with the unit PharmacoTherapy, -Epidemiology & -Economics to conduct scientific research and teach pharmacy and pharmaceutical sciences students.

NWO-VENI laureate Prof. Hak and his multidisciplinary team have supervised >30 PhD theses on the validity of scientific statistical and epidemiological causal design methods to assess (side-) effects of drugs and vaccines using Real-World Big Health Care and Biobank Data. Scientific methods consider a variety of designs such as case-control, cohort, case-only, sibling designs, instrumental variable analysis, propensity score analysis often in combination with RCTs, meta-analyses and Individual Patient Data designs. His scientific work led to >400 peer-reviewed publications till 2021 (Web of Science H-index 44, >8,000 citations). As leader of the PharmLines Initiative, a public-private collaboration between Lifelines BV-UMCG-RUG, he initiates and co-supervises research in the area of Precision Medicine with linked biobank, genetic, clinical, pharmacological and health care data of >80,000 persons from the Northern region. Topics mainly concern the pharmaco-epidemiology of preventive medications as well as vaccinations. In addition, his team supports the societal impact by studying the optimal methods to implement innovations in the area of sustainable drug applications and  vaccination strategies (e.g. drug repurposing, data science technologies to support optimal drug use, development of infection risk profiles and vaccination passport).Prof. Hak is program director of the two-year Groningen Research Master Medical Pharmaceutical Sciences. As a director he implemented innovations regarding the extension of research tracks. He further introduced a strong mentorate for students, monitoring of research projects, clear selection criteria for examiners and committee evaluations of research projects, which resulted in a Top-label in 2017 and 2019 by the influential Dutch Keuzegids (MPS belongs to the top-10%). As educational director Pharmacy (>100 faculty, approx 1,000 students) he applies his broad expertise to lead the cluster Pharmacy.

> 100 affiliated educational staff, approx. 1,000 bachelor and master students pharmacy-medical pharmaceutical sciences

Two-year research master Medical Pharmaceutical Sciences, Groningen Research Institute of Pharmacy. Approximately 50 students, Top-label (Keuzegids) 2017, 2019